CSIMarket
 
United Therapeutics Corporation  (UTHR)
Other Ticker:  
 
 

United Therapeutics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

United Therapeutics Corporation inventory turnover ratio, the United Therapeutics Corporation's ability to sell and replace its inventory in the forth quarter 2023, sequentially increased to 2.44 in the fourth quarter 2023, UTHR's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the United Therapeutics in Dec 31 2023 quarter, has decreased to 150 days, compare to 153 days, in the Sep 30 2023 quarter.

Within Healthcare sector 112 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 501 in the third quarter 2023, to 742.

UTHR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is United Therapeutics Corporation Market Share?

What is Inventory Turnover Ratio?


UTHR Inventory Turnover Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Inventory Growth 9.61 % 14.62 % 14.91 % 16.21 % 8.74 %
Y / Y Cost of Sales Growth 20.75 % 88.44 % 115.82 % 101.93 % 69.94 %
Inventory Turnover Ratio (TTM) 2.44 2.38 2.13 1.85 1.63
UTHR's Total Ranking # 742 # 501 # 433 # 651 # 1138
Average inventory processing period 150 153 171 198 223
Seq. Inventory Growth 7.19 % 0.97 % 0.78 % 0.49 % 12.09 %
Seq. Cost of Sales Growth 1.28 % 9.36 % 22.56 % -11.05 % 58.06 %



Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 34
Healthcare Sector # 113
Overall Market # 742

Inventory Turnover Ratio Statistics
High Average Low
2.88 1.5 0.6
(Dec 31 2013)   (Mar 31 2016)




Financial Statements
United Therapeutics's Inventories $ 112 Millions Visit UTHR's Balance sheet
United Therapeutics's Cost of Revenues TTM $ 258 Millions Visit UTHR's Income Statement
What are UTHR's Sales? Visit UTHR's Sales by Segment

Other Inventory Turnover Ratios
United Therapeutics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
UTHR's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for UTHR's Competitors
Inventory Turnover Ratio for UTHR's Suppliers
Inventory Turnover Ratio for UTHR's Customers

You may also want to know
UTHR's Sales Growth Rates UTHR's Pe Price to earnings ratio UTHR's Receivables Turnover Ratio UTHR's Stock Quote
UTHR's Net Income Growth Rates UTHR's Ps Price to Sales ratio UTHR's Sales per Employee UTHR's Asset Turnover Ratio
UTHR's Net Margin UTHR's Pb Price to Book ratio UTHR's Financial Strength Ratios UTHR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2023 Inventories at quarter ending Dec 31 2023
Veracyte inc   6.25 $ 88.913  Millions$ 14  Millions
Star Equity Holdings Inc   6.12 $ 33.859  Millions$ 6  Millions
Patterson Companies Inc   5.96 $ 5,166.391  Millions$ 867  Millions
Avantor Inc   5.30 $ 4,603.400  Millions$ 868  Millions
Lifemd Inc   5.28 $ 18.000  Millions$ 3  Millions
Incyte Corporation  5.18 $ 254.990  Millions$ 49  Millions
Enzo Biochem Inc  5.13 $ 49.539  Millions$ 10  Millions
Abbvie inc   5.11 $ 20,415.000  Millions$ 3,992  Millions
Integer Holdings Corporation  5.09 $ 1,178.000  Millions$ 232  Millions
Exact Sciences Corporation  5.08 $ 654.248  Millions$ 129  Millions
Cytosorbents Corporation  4.99 $ 13.000  Millions$ 3  Millions
Warby Parker Inc   4.86 $ 304.000  Millions$ 63  Millions
Cryoport inc   4.84 $ 133.923  Millions$ 28  Millions
Twist Bioscience Corporation  4.84 $ 168.474  Millions$ 35  Millions
Henry Schein Inc  4.58 $ 8,478.000  Millions$ 1,852  Millions
Catalyst Pharmaceuticals Inc   4.54 $ 51.967  Millions$ 11  Millions
Vericel Corporation  4.51 $ 61.940  Millions$ 14  Millions
Ufp Technologies Inc   4.42 $ 287.000  Millions$ 65  Millions
Precision Optics Corporation Inc   4.41 $ 13.019  Millions$ 3  Millions
Catalent Inc   4.35 $ 3,363.000  Millions$ 773  Millions
Bristol myers Squibb Company  4.25 $ 10,693.000  Millions$ 2,517  Millions
Integrated Biopharma Inc  4.25 $ 45.487  Millions$ 11  Millions
Blueprint Medicines Corporation  4.20 $ 75.795  Millions$ 18  Millions
Escalon Medical Corp   4.16 $ 6.730  Millions$ 2  Millions
West Pharmaceutical Services Inc   4.13 $ 1,820.000  Millions$ 441  Millions
Inspire Medical Systems inc   3.98 $ 96.000  Millions$ 24  Millions
Envista Holdings Corporation  3.94 $ 1,126.000  Millions$ 285  Millions
Ge Healthcare Technologies Inc   3.93 $ 8,465.000  Millions$ 2,152  Millions
Akebia Therapeutics Inc   3.92 $ 74.149  Millions$ 19  Millions
Gilead Sciences Inc   3.90 $ 6,498.000  Millions$ 1,665  Millions

Date modified: 2024-02-21T20:48:31+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com